Log in to save to my catalogue

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myel...

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5e6a8716f6d4f72afb2988be3482362

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

About this item

Full title

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-08, Vol.12 (1), p.5172-5172, Article 5172

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Chromothripsis is detectable in 20–30% of newly diagnosed multiple myeloma (NDMM) patients and is emerging as a new independent adverse prognostic factor. In this study we interrogate 752 NDMM patients using whole genome sequencing (WGS) to investigate the relationship of copy number (CN) signatures to chromothripsis and show they are highly associ...

Alternative Titles

Full title

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b5e6a8716f6d4f72afb2988be3482362

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5e6a8716f6d4f72afb2988be3482362

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-25469-8

How to access this item